The nitric oxide pathway in pulmonary arterial hypertension: pathomechanism, biomarkers and drug targets

Z Lázár, A Bikov - Current Medicinal Chemistry, 2020 - ingentaconnect.com
The altered Nitric Oxide (NO) pathway in the pulmonary endothelium leads to increased
vascular smooth muscle tone and vascular remodelling, and thus contributes to the …

[HTML][HTML] Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease

P Sivapalan, A Bikov, JU Jensen - Diagnostics, 2021 - mdpi.com
Treating patients hospitalised with acute exacerbations of chronic obstructive pulmonary
disease (COPD) usually involves administering systemic corticosteroids. The many …

Nitric Oxide as a Diagnostic and Therapeutic Tool in Respiratory Diseases

K Gulati, SK Thokchom, A Ray - Nitric Oxide: From Research to …, 2023 - Springer
Nitric oxide (NO) is a gasotransmitter that plays a vital role in diverse biological processes.
NO is a fundamental component in regulating cardiovascular functions, smooth muscle tone …

[PDF][PDF] Using blood eosinophil count as a biomarker to guide corticosteroid treatment for chronic obstructive pulmonary disease. Diagnostics. 2021; 11 (2): 236

P Sivapalan, A Bikov, JU Jensen - 2021 - pdfs.semanticscholar.org
Treating patients hospitalised with acute exacerbations of chronic obstructive pulmonary
disease (COPD) usually involves administering systemic corticosteroids. The many …

Current Approaches to COPD in 2019

A Corlăteanu - Current Respiratory Medicine Reviews, 2019 - ibn.idsi.md
Rezumat Chronic Obstructive Pulmonary Disease (COPD) remains the fourth leading cause
of chronic morbidity and mortality at the global level, and it represents a major problem for …

[PDF][PDF] downloaded from the King's Research Portal at https://kclpure. kcl. ac. uk/portal

T Harries - 2021 - kclpure.kcl.ac.uk
Background The evidence that patients with mild or moderate COPD are likely to benefit
from inhaled corticosteroid (ICS) therapy by suffering fewer exacerbations is equivocal …